Possible warfarin interaction with menthol cough drops

Annals of Pharmacotherapy

Volumn 39, Issue 2, 2005, Pages 365-367

  Kassebaum, Paul J ^a,b   Shaw, Don L ^a   Tomich, Dave J ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

Cough drop; Menthol; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; CYTOCHROME P450 ISOENZYME; EYE OINTMENT; FLUTICASONE; GENTEAL; GLYCERYL TRINITRATE; LANSOPRAZOLE; LISINOPRIL; LORATADINE; MENTHOL; NEFAZODONE; NIFEDIPINE; SIMVASTATIN; SPIRONOLACTONE; TERAZOSIN; WARFARIN;

ADULT; ANAMNESIS; ARTICLE; CARDIOVERSION; CASE REPORT; COUGHING; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG INHIBITION; FLU LIKE SYNDROME; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TREATMENT WITHDRAWAL;

COUGH; DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MENTHOL; MIDDLE AGED; WARFARIN;

EID: 12844268531     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E537     Document Type: Article

References (9)

1. Harder S, Thurmann P. Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet 1996;30:416-44.
2. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108(suppl):231S-46S.
3. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Gelal A, Guven H, Balkan D, Artok L, Benowitz NL. Influence of menthol on caffeine disposition and pharmacodynamics in healthy female volunteers. Eur J Clin Pharmacol 2003;59:417-22.
5. Madyastha KM, Srivatsan V. Studies on the metabolism of 1-menthol in rats. Drug Metab Dispos 1988;16:765-72.
6. Austin CA, Shephard EA, Pike SF, Rabin BR, Phillips IR. The effect of terpenoid compounds on cytochrome P-450 levels in rat liver. Biochem Pharmacol 1988;37:2223-9.
7. De-Olivera ACAX, Fidalgo-Neto AA, Paumgartten FJR. In vitro inhibition of liver monooxygenases by β-ionone, 1,9-cineole, (-)-menthol and terpinol. Toxicology 1999;135:33-41.
8. Wacher V, Wong S, Wong HT. Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-α-tocopheryl pol(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J Pharm Sci 2002;91: 77-90.
9. Dresser GK, Wacher V, Wong S, Wong HT, Bailey DG. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo. Clin Pharmacol Ther 2002;72: 247-55.